A Pennsylvania Court judge has ordered pharmaceutical company Bristol-Myers Squibb Co. to stop inflating the wholesale price of its drugs purchased by Pennsylvania’s pharmaceutical drug programs for the poor and for the elderly. Commonwealth Court Judge Robert E. Simpson said in his order that Bristol-Myers, headquartered in New York City, violated the Pennsylvania Unfair Trade Practices and Consumer Protection Law with unfair or deceptive practices. The judge said Bristol-Myers owes $27.6 million to the State of Pennsylvania for the price of drugs charged in violation of fair trade practices.
The State of Pennsylvania filed suit against 13 pharmaceutical companies in 2004, alleging that the companies inflated the wholesale prices of drugs purchased by state-funded prescription drug programs, including the state Medicaid program for the poor, the state prescription drug program for senior citizens, the Pharmaceutical Assistance Contract for the Elderly, and a medical-prescription plan for state employees, the Pennsylvania Employees Benefit Trust Fund.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.